Corbus Pharmaceuticals Holdings logo
Corbus Pharmaceuticals Holdings CRBP
$ 9.53 0.21%

Annual report 2025
added 03-09-2026

report update icon

Corbus Pharmaceuticals Holdings Depreciation & Amortization 2011-2026 | CRBP

Annual Depreciation & Amortization Corbus Pharmaceuticals Holdings

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
233 K 588 K 641 K 763 K 1 M 1.12 M 739 K 494 K 256 K 87.7 K 43.9 K 10.4 K - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.12 M 10.4 K 498 K

Quarterly Depreciation & Amortization Corbus Pharmaceuticals Holdings

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
100 K 100 K 81 K - 200 K 200 K 152 K - 200 K 200 K 182 K - 191 K 192 K 196 K - 792 K 536 K 272 K - 202 K 320 K 319 K - 158 K 156 K 153 K - 132 K 124 K 81.9 K - 127 K 33 K 31.5 K - 20.5 K 37.2 K 17.3 K - 14.7 K 6.12 K 5.37 K - 5.03 K 180 - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
792 K 180 158 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer Depreciation & Amortization Price % 24h Market Cap Country
AbCellera Biologics AbCellera Biologics
ABCL
18.4 M $ 3.52 -1.12 % $ 1.05 B canadaCanada
Acorda Therapeutics Acorda Therapeutics
ACOR
31.7 M - -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
7 K - 4.01 % $ 150 M canadaCanada
Advaxis Advaxis
ADXS
369 K - -9.65 % $ 45.9 M usaUSA
I-Mab I-Mab
IMAB
23.9 M - - $ 866 M chinaChina
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
744 K - - $ 1.01 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
131 K - -10.17 % $ 12.2 K usaUSA
Albireo Pharma Albireo Pharma
ALBO
274 K - -0.23 % $ 916 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
63 K - 10.36 % $ 9.8 M usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
1.13 M $ 0.8 1.27 % $ 4.36 M chinaChina
Adverum Biotechnologies Adverum Biotechnologies
ADVM
3.65 M - - $ 86.2 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.51 M - - $ 26.5 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
3.13 M - - $ 10.1 M usaUSA
Atea Pharmaceuticals Atea Pharmaceuticals
AVIR
416 K $ 6.12 1.16 % $ 499 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
3.02 M $ 6.62 -0.15 % $ 181 M israelIsrael
Akero Therapeutics Akero Therapeutics
AKRO
18 K - - $ 3.67 B usaUSA
Athersys Athersys
ATHX
1.43 M - 3.77 % $ 22.4 M usaUSA
Akouos Akouos
AKUS
2.49 M - 0.23 % $ 488 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
66 K - 2.71 % $ 14 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
27 K - 1052.0 % $ 415 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
363 K - 3.16 % $ 1.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
58 K - 5.93 % $ 314 M canadaCanada
AlloVir AlloVir
ALVR
398 K - 4.14 % $ 49.1 M usaUSA
BioCardia BioCardia
BCDA
84 K $ 1.36 7.09 % $ 28.8 M usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
6.43 M $ 14.64 1.92 % $ 215 M usaUSA
Aptinyx Aptinyx
APTX
122 K - -39.0 % $ 4.57 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
32 K - -45.71 % $ 1.2 M canadaCanada
AVEO Pharmaceuticals AVEO Pharmaceuticals
AVEO
67 K - - $ 521 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
162 K - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
5.38 M $ 2.65 0.38 % $ 16.6 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
7.55 M $ 1.5 -0.66 % $ 383 M britainBritain
Athira Pharma Athira Pharma
ATHA
970 K - - $ 269 M usaUSA
Aravive Aravive
ARAV
886 K - -13.39 % $ 1.45 M usaUSA
Actinium Pharmaceuticals Actinium Pharmaceuticals
ATNM
197 K $ 1.15 3.6 % $ 34.6 M usaUSA